An underground market for unapproved slimming medications is propelled by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.
Experimental Treatment Acquiring Popularity Via Social Media
The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its alleged weight-reducing properties. Viewers are urged to contact these profiles privately for source information, while also receiving discount codes.
Thriving Commerce on Social Networks
Additionally, a robust market exists on messaging services, where communities with thousands of participants share comparison photos, injection guides and claims of next-day UK delivery. Vendors market the drug there before directing customers to other platforms for transactions.
Learning About Retatrutide
Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could assist individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Medical Professionals Express Concerns
However, physicians and chemists have warned that the sale of what is still an unlicensed medication in the United Kingdom is a cause for concern and could result in individuals injecting substances of unknown origin.
Several professionals said the demand for retatrutide could be connected to the increasing cost of licensed slimming treatments such as Mounjaro.
Regulatory Status and Implementation
Selling the unapproved drug on social media or Telegram is illegal in the United Kingdom, as it is an unapproved medication that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.
Some influencers try to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still breach medicines, marketing, and customer regulations, potentially leading to fines, legal action or prison.
Platform Reaction and Content Removal
Based on TikTok, the service has removed problematic content and banned associated keywords and search suggestions. The company said it was committed to maintaining the service secure and allocating resources in strengthening enforcement strategies.
Online Marketplace Activities
Investigations also discovered communities with up to 9,000 participants selling the experimental drug using the platform's built-in search feature, which functions like a online catalog. Entering “retatrutide” instantly displays channels with numerous of members, populated with photos of slimming results, positive reviews and detailed guides for preparing or injecting at home.
Within moments of entering one group, a vendor posted WhatsApp details, where the majority of transactions occur. The seller sent an guidebook and promised shipping within two days. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None inquired about body mass, medical conditions or previous experience.
Item Details and Pricing
Inside these groups, messages show dark colored packages with Royal Mail labels, stating to include new batches. One communication read: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, mixed at home with purified liquid, or pre-filled injectors usually priced at £160 for 20 milligrams. When questioned how much time a pen should be used, vendors give contradictory answers ranging from a several days to “depends on your body”.
Service Oversight and Safety Actions
A spokesperson for Telegram stated it regularly monitored harmful material on its service including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“People are administering substances they cannot confirm. Although the science behind retatrutide is sound, these digital products may not include what they advertise,” stated a pharmacy expert, the head of pharmacy at Chemist4U.
A medical professional of an online medical service connected the increase in demand to recent price rises for authorized slimming drugs such as Mounjaro. “With prices rising, individuals are turning to social media. But fake treatments are highly risky. You cannot know what’s contained or whether the environment they were made in was clean,” she explained.
Her team has previously encountered individuals injured by self-injection from unverified sources. “We understand the frustration, but buying from messaging apps or WhatsApp is taking chances with your well-being,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Position
A representative from Eli Lilly said the substance was in phase 3 clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this point no one can market [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a company investigational substance not yet authorized … may expose users to potentially serious health risks”.
